Vikram Khanna
Fondatore presso Ikarian Capital LLC
Profilo
Vikram Khanna is the founder and Chief Investment Officer of Ikarian Capital LLC, which was founded in 2015.
He is currently the Director at OrphAI Therapeutics, Inc. Mr. Khanna has a graduate degree from Keck Graduate Institute of Applied Life Sciences.
Posizioni attive di Vikram Khanna
| Società | Posizione | Inizio |
|---|---|---|
AI Therapeutics, Inc.
 AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Direttore/Membro del Consiglio | - |
Ikarian Capital LLC
 Ikarian Capital LLC Investment ManagersFinance Ikarian Capital LLC (Ikarian) is an independent registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 2015 by its founders, Neil Shahrestani and Chart Westcott. Ikarian provides discretionary investment advisory services to clients structured as (i) private investment funds comprised of sophisticated, qualified investors; and (ii) separately managed accounts. | Fondatore | 01/01/2015 |
Formazione di Vikram Khanna
| Keck Graduate Institute of Applied Life Sciences | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Ikarian Capital LLC
Ikarian Capital LLC Investment ManagersFinance Ikarian Capital LLC (Ikarian) is an independent registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 2015 by its founders, Neil Shahrestani and Chart Westcott. Ikarian provides discretionary investment advisory services to clients structured as (i) private investment funds comprised of sophisticated, qualified investors; and (ii) separately managed accounts. | Finance |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Health Technology |
- Borsa valori
- Insiders
- Vikram Khanna
